IFO50283 IMR-32
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | IFO50283 | Cell Name | IMR-32 |
---|---|---|---|
Profile | Human nueroblastoma cell line. | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | M | Age | 13-month-old |
Identity | available | Tissue for Primary Cancer | neural |
Case history | neuroblastoma arizing at abdomen | Metastasis | |
Tissue Metastasized | Genetics | N-myc amplification was reported. | |
Life Span | infinite | Crisis PDL | |
Morphology | fibroblast-like | Character | transplantable to nude mice |
Classify | tumor | Established by | Nichols, W. W. et al. |
Registered by | Kaisho,Y. | Regulation for Distribution | |
Comment | Year | 1990 | |
Medium | Eagle's minimal essential medium with non-essential amino acids and 10% heat-inactivated FBS | Methods for Passages | trypsin-EDTA |
Cell Number on Passage | Race | Caucasian | |
CO2 Conc. | 5 % | Tissue Sampling | |
Tissue Type | sympatho-adrenal cell |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:2121721 | Monoclonal antibodies to disialogangliosides: characterization of antibody-mediated cytotoxicity against human melanoma and neuroblastoma cells in vitro. Kawashima I,Tada N,Fujimori T,Tai T J Biochem. 1990 Jul;108(1):109-15 |
Pubmed id:841332 | Enzyme polymorphisms as genetic signatures in human cell cultures. O'Brien SU,Kleiner G,Olson R,Shannon JE Science. 1977 Mar 25;195(4284):1345-8 |
Pubmed id:5459762 | Definition of a continuous human cell line derived from neuroblastoma. Tumilowicz JJ,Nichols WW,Cholon JJ,Greene AE Cancer Res. 1970 Aug;30(8):2110-8 |
Images |
---|
Movies |
---|
LOT Information
Cell No. | IFO50283 | Cell Name | |
---|---|---|---|
LOT No. | 12022005 | Lot Specification | distribution |
Medium | Eagle's minimal essential medium with non-essential amino acids and 10% heat-inactivated fetal bovine serum (FBS lot; GIBCO 4218333S) | Temperature | 37 C |
Cell Density at Seeding | 0.6 - 1.4 x 10^5 cells/ml | Methods for Passages | 0.25% trypsin and 0.02% EDTA. (Alternatively, cells can be detached with Ca, Mg-free PBS treatment.) |
Doubling Time | approx. 39 hrs | Cell Number in Vial (cells/1ml) | 2.8 x 10^6 |
Viability at cell freezing (%) | 97.4 | Antibiotics Used | free |
Passage Number | P60 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), LD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | D5S818:11,12 D13S317:9 D7S820:9,10 D16S539:8 VWA:15 TH01:7,9.3 AM:X,Y TPOX:11 CSF1PO:11,12 |
|
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - culture medium | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | IFO50283 | Cell Name | IMR-32 |
---|---|---|---|
LOT No. | 1059 | Lot Specification | distribution |
Medium | E.MEM with NEAA, 90% ; heat-inactivated FBS, 10% | Temperature | 37 C |
Cell Density at Seeding | Methods for Passages | trypsin-EDTA | |
Doubling Time | Cell Number in Vial (cells/1ml) | 2 x 10^6 | |
Viability at cell freezing (%) | 89 | Antibiotics Used | free |
Passage Number | P57 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NP, G6PD(type B), PepB |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Exoteric Gene | ||
Medium for Freezing | 10% DMSO, 20% serum (final conc.) - culture medium | CO2 Conc. | |
Viability immediately after thawing (%) | Additional information |